[18F]BF3-BPA

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug Name[18F]BF3-BPA
Drug Alias Name[18F]BF3-BPABR-02[18F](R)-BBPA[18F]BBPA
ClassificationDiagnostic agent (In vivo) > Contrast agentDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Fluorine > 18F +[6] 
Mechanisms of ActionIonising radiation emitters
TargetsNot applicable
Therapy Area/IndicationsBrain contrast agentsBrain NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBoomRay Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Huayi Nuclear Medicine Co LtdBoomRay Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsBrain contrast agentsBrain Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A